PURPOSE
Although acute pouchitis after ileal pouch-anal anastomosis is common and easily treated, continuous pouch inflammation seen clinically as chronic, antibiotic-dependent pouchitis, and/or Crohn’s disease remains a difficult management problem. Compared with ulcerative colitis, indeterminate colitis patients undergoing ileal pouch-anal anastomosis have a higher incidence of continuous pouch inflammation, which may represent persistent immune reactivity to microbial antigens. Antibody responses to three microbial antigens (oligomannan anti-Saccharomyces cerevisiae, outer membrane porin C of Escherichia coli, and an antigen (I2) from Pseudomonas flourescens) are more commonly seen in Crohn’s disease, whereas antibodies to a cross-reactive antigen (perinuclear antineutrophil cytoplasmic antibodies) is more suggestive of ulcerative colitis. We examined whether preoperative serologic responses to these antigens were associated with Crohn’s disease in indeterminate colitis patients after ileal pouch-anal anastomosis.
METHODS
Twenty-eight indeterminate colitis patients undergoing ileal pouch-anal anastomosis were prospectively assessed for the development of pouchitis or Crohn’s disease. Serologic responses were determined by enzyme-linked immunosorbent assay and immunofluorescence. Patients were classified based on four predominant profiles of antibody expression. Antibody profiles were determined before knowledge of clinical outcome.
RESULTS
Median follow-up was 38 (range, 3–75) months. Of 16 patients (61 percent) who developed pouch inflammation, 4 (25 percent) had acute pouchitis and 12 (75 percent) had continuous pouch inflammation (9 had chronic pouchitis, 3 had Crohn’s disease). No preoperative clinical factor predicted the development of these pouch complications. Overall, 16 patients (57 percent) had a positive antibody reactivity profile. Serologic expression of any marker alone did not predict the development of continuous pouch inflammation. However, continuous pouch inflammation developed in 10 of 16 patients (63 percent) who had a positive antibody reactivity profile compared with only 2 of 12 patients (17 percent) who had a negative antibody reactivity profile (P = 0.015).
CONCLUSIONS
Indeterminate colitis patients who have a positive antibody reactivity profile before ileal pouch-anal anastomosis have a significantly higher incidence of continuous pouch inflammation after surgery than those with a negative profile.
Similar content being viewed by others
REFERENCES
PW Marcello PL Roberts DJ Schoetz et al. (1993) ArticleTitleLong-term results of the ileoanal pouch procedure Arch Surg 128 500–4 Occurrence Handle1:STN:280:DyaK3s3ls1OnsQ%3D%3D Occurrence Handle8489382
VW Fazio Y Ziv JM Church et al. (1995) ArticleTitleIleal pouch-anal anastomoses complications and function in 1005 patients Ann Surg 222 120–7 Occurrence Handle1:STN:280:DyaK2Mzms1yiuw%3D%3D Occurrence Handle7639579
AP Meagher R Farouk RR Dozois et al. (1998) ArticleTitleJ ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients Br J Surg 85 800–3 Occurrence Handle1:STN:280:DyaK1czjtVartA%3D%3D Occurrence Handle9667712
AA Deutsch RS McLeod J Cullen Z Cohen (1991) ArticleTitleResults of the pelvic-pouch procedure in patients with Crohn’s disease Dis Colon Rectum 34 475–7 Occurrence Handle1:STN:280:DyaK3M3ktlGmug%3D%3D Occurrence Handle2036927
NH Hyman VW Fazio WB Tuckson IC Lavery (1991) ArticleTitleConsequences of ileal pouch-anal anastomosis for Crohn’s colitis Dis Colon Rectum 34 653–7 Occurrence Handle1:STN:280:DyaK3MzgvFCmtw%3D%3D Occurrence Handle1855421
BT Gemlo D Wong DA Rothenberger SM Goldberg (1992) ArticleTitleIleal pouch-anal anastomosis. Patterns of failure Arch Surg 127 784–7 Occurrence Handle1524477 Occurrence Handle1:STN:280:DyaK38zpvVCitg%3D%3D
PM Sagar RR Dozois BG Wolff (1996) ArticleTitleLong-term results of ileal pouch-anal anastomosis in patients with Crohn’s disease Dis Colon Rectum 39 893–8 Occurrence Handle1:STN:280:DyaK28zivVWrtQ%3D%3D Occurrence Handle8756845
JM Regimbeau Y Panis M Pocard et al. (2001) ArticleTitleLong-term results of ileal pouch-anal anastomosis for colorectal Crohn’s disease Dis Colon Rectum 44 769–78 Occurrence Handle11391134 Occurrence Handle1:STN:280:DC%2BD3MzhvFOqsg%3D%3D
AB Price (1978) ArticleTitleOverlap in the spectrum of non-specific inflammatory bowel disease: “colitis indeterminate” J Clin Pathol 31 567–77 Occurrence Handle1:STN:280:DyaE1c3hvVGqsA%3D%3D Occurrence Handle670413
PW Marcello DJ Schoetz SuffixJr PL Roberts et al. (1997) ArticleTitleEvolutionary changes in the pathologic diagnosis after the ileoanal pouch procedure Dis Colon Rectum 40 263–9 Occurrence Handle9118738 Occurrence Handle1:STN:280:DyaK2s3ktVCgug%3D%3D
WA Koltun DJ Schoetz SuffixJr PL Roberts JJ Murray JA Coller MC Veidenheimer (1991) ArticleTitleIndeterminate colitis predisposes to perineal complications after ileal pouch-anal anastomosis Dis Colon Rectum 34 857–60 Occurrence Handle1914717 Occurrence Handle1:STN:280:DyaK38%2Fgs12mtg%3D%3D
KG Atkinson DA Owen G Wankling (1994) ArticleTitleRestorative proctocolectomy and indeterminate colitis Am J Surg 167 516–8 Occurrence Handle10.1016/0002-9610(94)90248-8 Occurrence Handle1:STN:280:DyaK2c3ktFersA%3D%3D Occurrence Handle8185040
JH Bodzin SN Klein SG Priest (1995) ArticleTitleIleoproctostomy is preferred over ileoanal pull-through in patients with indeterminate colitis Am Surg 61 590–3 Occurrence Handle1:STN:280:DyaK2MzhsVSlsg%3D%3D Occurrence Handle7793739
CS Yu JH Pemberton D Larson (2000) ArticleTitleIleal pouch-anal anastomosis in patients with indeterminate colitis. Long-term results Dis Colon Rectum 43 1487–96 Occurrence Handle11089581 Occurrence Handle1:STN:280:DC%2BD3M%2Fkt1GjsQ%3D%3D
MT Dayton KR Larsen DD Christiansen (2002) ArticleTitleSimilar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate colitis vs ulcerative colitis Arch Surg 137 690–5 Occurrence Handle10.1001/archsurg.137.6.690 Occurrence Handle12049540
CP Delaney FH Remzi T Gramlich B Dadvand VW Fazio (2002) ArticleTitleEquivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis Ann Surg 236 43–9 Occurrence Handle12131084
WG Rudolph SM Uthoff TL McAuliffe ET Goode RE Petras S Galandiuk (2002) ArticleTitleIndeterminate colitis: the real story Dis Colon Rectum 45 1528–34 Occurrence Handle12432302
A Saxon F Shanahan C Landers T Ganz S Targan (1990) ArticleTitleA distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease J Allergy Clin Immunol 86 202–10 Occurrence Handle1:STN:280:DyaK3czkslWntQ%3D%3D Occurrence Handle2200820
M Oudkerk-Pool PM Ellerbroek BU Ridwan et al. (1993) ArticleTitleSerum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment Gut 34 46–50 Occurrence Handle1:STN:280:DyaK3s7mt1GjtQ%3D%3D Occurrence Handle8432451
P Aitola A Miettinen A Mattila et al. (1995) ArticleTitleEffect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis J Clin Pathol 48 645–7 Occurrence Handle1:STN:280:DyaK28%2FgsFymtw%3D%3D Occurrence Handle7560172
EA Vasiliauskas SE Plevy CJ Landers et al. (1996) ArticleTitlePerinuclear anti-neutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup Gastroenterology 110 1810–9 Occurrence Handle1:STN:280:DyaK283jvFKruw%3D%3D Occurrence Handle8964407
JF Quinton B Sendid D Reumaux et al. (1998) ArticleTitleAnti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role Gut 42 788–91 Occurrence Handle1:CAS:528:DyaK1cXlslChs7o%3D Occurrence Handle9691915 Occurrence Handle10.1136/gut.42.6.788
CL Sutton H Yang Z Li JI Rotter SR Targan J Braun (2000) ArticleTitleFamilial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn’s disease Gut 46 58–63 Occurrence Handle10.1136/gut.46.1.58 Occurrence Handle1:STN:280:DC%2BD3c%2FmvFGjsw%3D%3D Occurrence Handle10601056
O Cohavy D Bruckner LK Gordon et al. (2000) ArticleTitleColonic bacteria express an ulcerative colitis pANCA-related protein epitope Infect Immun 68 1542–8 Occurrence Handle10.1128/IAI.68.3.1542-1548.2000 Occurrence Handle1:CAS:528:DC%2BD3cXhsVKrsLY%3D Occurrence Handle10678972
CL Sutton J Kim A Yamane et al. (2000) ArticleTitleIdentification of a novel bacterial sequence associated with Crohn’s disease Gastroenterology 119 23–31 Occurrence Handle1:CAS:528:DC%2BD3cXlsFGlt74%3D Occurrence Handle10889151
PR Fleshner EA Vasiliauskas LY Kam et al. (2001) ArticleTitleHigh level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis Gut 49 671–7 Occurrence Handle10.1136/gut.49.5.671 Occurrence Handle1:STN:280:DC%2BD3MrltlKmuw%3D%3D Occurrence Handle11600470
CJ Landers O Cohavy R Misra et al. (2002) ArticleTitleSelected loss of tolerance evidenced by Crohn’s disease–associated immune responses to auto- and microbial antigens Gastroenterology 123 689–99 Occurrence Handle1:CAS:528:DC%2BD38Xntl2mtbk%3D Occurrence Handle12198693
JL Lohmuller JH Pemberton RR Dozois et al. (1990) ArticleTitlePouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis Ann Surg 211 622–7 Occurrence Handle1:STN:280:DyaK3c3ltlanuw%3D%3D Occurrence Handle2339922
NG Kock N Darle L Hulten (1977) ArticleTitleIleostomy Curr Probl Surg 14 1–52 Occurrence Handle1:STN:280:DyaE1c%2Fgt1Ohug%3D%3D Occurrence Handle10.1016/S0011-3840(77)80065-8 Occurrence Handle902503
WJ Sandborn (1994) ArticleTitlePouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment Gastroenterology 107 1856–60 Occurrence Handle1:STN:280:DyaK2M%2FkslWluw%3D%3D Occurrence Handle7958702
MV Madden AS McIntyre RJ Nicholls (1994) ArticleTitleDouble-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis Dig Dis Sci 39 1193–6 Occurrence Handle1:STN:280:DyaK2c3lvV2msg%3D%3D Occurrence Handle8200250
B Shen JP Achkar BA Lashner et al. (2001) ArticleTitleA randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis Inflamm Bowel Dis 7 301–5 Occurrence Handle10.1097/00054725-200111000-00004 Occurrence Handle1:STN:280:DC%2BD3MnnsVeltQ%3D%3D Occurrence Handle11720319
NA Shepherd L Hulten GN Tytgat et al. (1989) ArticleTitleWorkshop: pouchitis Int J Colorectal Dis 4 205–29 Occurrence Handle10.1007/BF01644986 Occurrence Handle1:STN:280:DyaK3c7jt1Wlsg%3D%3D Occurrence Handle2693561
WJ Sandborn WJ Tremaine KP Batts et al. (1995) ArticleTitleFecal bile acids, short chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis Dig Dis Sci 40 1474–83 Occurrence Handle1:CAS:528:DyaK2MXnsVGlsbY%3D Occurrence Handle7628271
E Ricart R Panaccione EV Loftus WJ Tremaine WJ Sandborn (1999) ArticleTitleSuccessful management of Crohn’s disease of the ileoanal pouch with infliximab Gastroenterology 117 429–32 Occurrence Handle1:STN:280:DyaK1MzltVejtA%3D%3D Occurrence Handle10419926
EA Vasiliauskas LY Kam LC Karp et al. (2000) ArticleTitleMarker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics Gut 47 487–96 Occurrence Handle10.1136/gut.47.4.487 Occurrence Handle1:CAS:528:DC%2BD3cXnsVCrurs%3D Occurrence Handle10986208
GR D’Haens K Geboes M Peeters F Baert F Penninckx P Rutgeerts (1998) ArticleTitleEarly lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 262–7 Occurrence Handle1:STN:280:DyaK1c7hsVagsg%3D%3D Occurrence Handle9453485
F Shanahan (2001) ArticleTitleTurbo probiotics for IBD Gastroenterology 120 1297–8 Occurrence Handle1:STN:280:DC%2BD3M7mvFyiug%3D%3D Occurrence Handle11266396
M Vecchi P Gionchetti MB Bianchi et al. (1994) ArticleTitlep-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis Lancet 344 886–7 Occurrence Handle10.1016/S0140-6736(94)92859-2 Occurrence Handle1:STN:280:DyaK2czns1Gmuw%3D%3D Occurrence Handle7916418
WJ Sandborn CJ Landers WJ Tremaine et al. (1995) ArticleTitleAntineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis Am J Gastroenterol 90 740–6 Occurrence Handle1:STN:280:DyaK2M3ltVOnuw%3D%3D Occurrence Handle7733080
P Yang T Oresland G Jarnerot et al. (1996) ArticleTitlePerinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis Scand J Gastroenterol 31 594–8 Occurrence Handle1:STN:280:DyaK28zotFyrtA%3D%3D Occurrence Handle8789899
P Gupta H Andrew BS Kirschner (2002) ArticleTitleUsefulness of pANCA and ASCA in children with indeterminate colitis [abstract] Gastroenterology 122 A-11
Author information
Authors and Affiliations
Corresponding author
Additional information
Reprints are not available.
Supported by USPHS Grant PO 1 DK46763 and the Feintech Family Foundation.
About this article
Cite this article
Hui, T., Landers, C., Vasiliauskas, E. et al. Serologic Responses in Indeterminate Colitis Patients Before Ileal Pouch-Anal Anastomosis May Determine Those at Risk for Continuous Pouch Inflammation. Dis Colon Rectum 48, 1254–1262 (2005). https://doi.org/10.1007/s10350-005-0013-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-005-0013-0